Pharmaceutical blockade of the neonatal Fc receptor (FcRn) ameliorates autoimmunity, inflammation, and fibrosis in the antitopoisomerase-I antibody–driven mouse model of systemic sclerosis

Annals of the Rheumatic Diseases · Elsevier

Аннотация

Publication date: Available online 11 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Cuong Tran Manh, Christoph Liebel, Aleix Rius Rigau, Bas van der Woning, Piotr Zabrocki, Jörg H.W. Distler, Thuong Trinh-Minh

Читать у издателя →

Похожие статьи